Lynne Canne

Title: Lynne Canne: Innovator in Peptide Synthesis

Introduction

Lynne Canne is a prominent inventor based in Pacifica, CA (US). She has made significant contributions to the field of peptide synthesis, holding a total of 3 patents. Her work focuses on innovative methods for assembling peptides and proteins, which have important applications in biochemistry and pharmaceuticals.

Latest Patents

One of her latest patents is titled "Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution." This invention provides methods, apparatus, and kits for synthesizing assembled peptides and proteins on a solid phase. It involves the sequential ligation of three or more unprotected peptide segments using chemoselective and mild ligation chemistries in aqueous solution. Additionally, the patent outlines methods for monitoring solid phase sequential ligation reactions using MALDI or electrospray ionization mass spectrometry of reaction products.

Career Highlights

Throughout her career, Lynne Canne has worked with notable companies such as Gryphon Therapeutics, Inc. and Gryphon Sciences. Her expertise in peptide synthesis has positioned her as a valuable asset in the biotechnology sector.

Collaborations

Lynne has collaborated with esteemed colleagues, including Stephen B. H. Kent and Reyna J. Simon. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Lynne Canne's innovative work in peptide synthesis and her contributions to the scientific community underscore her role as a leading inventor. Her patents and collaborations reflect her commitment to advancing biochemistry and biotechnology.